Keyphrases
Human Epidermal Growth Factor Receptor 2 (HER2)
100%
Uterine Serous Carcinoma
100%
Serous Endometrial Intraepithelial Carcinoma
100%
Human Epidermal Growth Factor Receptor 2 Amplification
100%
Immunohistochemistry
93%
Fluorescence in Situ Hybridization
43%
Breast
25%
Scoring Criteria
18%
Targeted Therapy
12%
Human Epidermal Growth Factor Receptor 2-negative
12%
Tumor
6%
Clinical Trials
6%
Clinical Response
6%
Excision
6%
Small Biopsy
6%
Intratumoral Heterogeneity
6%
Invasive Component
6%
Discordance Rate
6%
Human Epidermal Growth Factor Receptor 2/neu
6%
Medicine and Dentistry
Carcinoma
100%
Epidermal Growth Factor Receptor 2
100%
Gamma Urogastrone
100%
Uterine Serous Carcinoma
100%
Immunohistochemistry
78%
Fluorescence in Situ Hybridization
36%
Targeted Therapy
10%
Biopsy
5%
Neoplasm
5%
Clinical Trial
5%
Pharmacology, Toxicology and Pharmaceutical Science
Carcinoma
100%
Epidermal Growth Factor Receptor 2
100%
Gamma Urogastrone
100%
Neoplasm
4%
Clinical Trial
4%
Agricultural and Biological Sciences
Epidermal Growth Factor Receptor
100%
Immunohistochemistry
78%
Fluorescence in Situ Hybridization
36%
Biochemistry, Genetics and Molecular Biology
Epidermal Growth Factor Receptor
100%
Fluorescence in Situ Hybridization
36%
Clinical Trial
5%